Developing new treatments for acute myeloid leukemia
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
This study is looking for better treatments for adults with acute myeloid leukemia (AML) by exploring the genetic factors of the disease and creating personalized therapies that could help improve survival and reduce the chances of relapse.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10862886 on NIH RePORTER |
What this research studies
This research focuses on improving therapies for adults with acute myeloid leukemia (AML), a condition with a low survival rate and high relapse rate after treatment. The team will investigate genetic and molecular pathways that contribute to AML and develop targeted therapies and immunotherapies tailored to specific genetic alterations in the disease. By utilizing a multidisciplinary approach, they aim to identify effective treatment options and understand how these therapies work, as well as which patients are most likely to benefit from them.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with acute myeloid leukemia.
Not a fit: Patients with other types of leukemia or those who are not adults may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for AML, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in developing targeted therapies for AML, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Abdel-Wahab, Omar — Sloan-Kettering Inst Can Research
- Study coordinator: Abdel-Wahab, Omar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.